Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Highlights from IMW 2019

Written by | 8 Nov 2019

Many of the 4,000 delegates at IMW in Boston this year, such as Professor Mohamad Mohty (Paris, France) highlighted the spirit of collaboration, with locals Professor Paul Richardson and Professor Noopur Raje discussing their highlights… read more.

Highlights from WCLC 2019

Written by | 21 Oct 2019

The IASLC WCLC meeting, held in Barcelona this year, covered many interesting topics and reported data from clinical trials relevant to the management of lung cancer. In the… read more.


Written by | 28 Sep 2019

Professor Kwee Yong (London, UK) details the results from the Tourmaline-MM3 study.

Lung cancer screening and its implications

Written by | 19 Jul 2019

Professor Bob Steele CBE (Dundee, UK) discusses the potential implementation of a National Screening Programme in the UK, and the view post-NELSON, as well as highlighting the next steps in… read more.

Translational oncology symposium

Written by | 18 Jul 2019

The use of tyrosine kinase inhibitors (TKIs) in the treatment of ALK-positive NSCLC is now well-established. Professor Ross Camidge (University of Colorado Cancer Centre, Denver, USA) described the lessons that… read more.

Mesothelioma trials update

Written by | 10 Jul 2019

Dr Popat gives an update of the ongoing studies in mesothelioma in the UK

UK impact of trial data

Written by | 8 Jul 2019

Dr Fiona McDonald (London, UK) discusses radical treatment for oligo metastatic NSCLC and if it should be the standard of care and Professor James Spicer (London, UK), the session Chair,  gives… read more.

Translational oncology: Tumour mutational burden and exploitation of DNA repair

Written by | 5 Jul 2019

Professor Ahmed gives an overview of one of the sessions in the BTOG Translational Oncology Symposium.

PACIFIC and beyond – the promise of immunotherapy

Written by | 10 May 2019

Correvio Pharma has resubmitted a New Drug Application (NDA) to the US FDA seeking approval for Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation (AF).

Advances in RRMM

Written by | 9 May 2019

Professor Kwee Yong (London, UK) details the results from the Tourmaline-MM3 study

Transplantation, Consolidation and Maintenance

Written by | 8 May 2019

  Autologous stem cell transplantation (ASCT) remains the standard of care option for those patients with newly-diagnosed multiple myeloma (MM) who are eligible for and able to tolerate… read more.

Integrating CAR T-Cell therapy into the treatment of myeloma

Written by | 7 May 2019

Professor Julie Vose (Nebraska, USA) updates us on the current status of BCMA CAR T-cell therapy.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.